MoonRise Bio AG

History from 21 Feb 2025

Nominal capital · CHFCHF 118k

SHAB published 26 Feb 2025 · legal date 21 Feb 2025
Company formed
Founded 21 Feb 2025
SHAB HR01-1006267685 ↗
SHAB published 1 Apr 2026 · legal date 23 Mar 2026
Capital increase
Likely financing
Paid in cash
Nominal capital
100’000 → 117’647.06
Shares
10’000’000 → 11’764’706
New shares, % of post-step shares
15.0% (1’764’706 new)
Aktienkapital neu: CHF 117'647.06 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 117'647.06 [bisher: CHF 100'000.00]. Aktien neu: 11'764'706 vinkulierte Namenaktien zu CHF 0.01 [bisher: 10'000'000 vinkulierte Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung.
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
- The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
- The company was founded less than six years before this capital increase.+0.5
- The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability
SHAB HR02-1006613596 ↗

Published by 5 Apr 2026

Record